# OnCo record robert-doebele (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/robert-doebele/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "robert-doebele" ;
  schema:name "Robert C. Doebele"@en ;
  schema:description "Lung cancer researcher who led the pooled analysis showing that entrectinib shrinks NTRK fusion-positive tumours of many kinds, and who studied how ROS1 and NTRK cancers escape targeted drugs."@en ;
  schema:url <https://onco.cc/people/robert-doebele/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  onco:tag "lung", "targeted-therapy" ;
  schema:jobTitle "Thoracic oncologist and drug developer" ;
  onco:cancers <https://onco.cc/cancers/ntrk-fusion-nsclc/>, <https://onco.cc/cancers/ros1-positive-nsclc/>, <https://onco.cc/cancers/nsclc/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-doebele-entrectinib-ntrk-lancet-oncol-2020/> .